Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 29, 2022 11:20 ET | Source: BioRestorative Therapies, Inc.

BioRestorative Therapies to Participate at the RHK Capital Disruptive Growth Conference on Dec. 5-6, 2022

MELVILLE N.Y., Nov. 29, 2022 (GLOBE NEWSWIRE) -- via InvestorWire – BioRestorative Therapies, Inc. (Nasdaq: BRTX) today announced that Lance Alstodt, its CEO, will be participating at the RHK...
May 03, 2021 06:00 ET | Source: BioRestorative Therapies, Inc.

BioRestorative Therapies Announces Compliance with SEC Reporting Requirements and “Stop Sign” Removal

MELVILLE, N.Y., May 03, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today...
April 05, 2021 06:27 ET | Source: BioRestorative Therapies, Inc.

BioRestorative Therapies Announces Appointment of Nickolay V. Kukekov, Ph.D to its Board of Directors

MELVILLE, N.Y., April 05, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today...
March 31, 2021 07:03 ET | Source: BioRestorative Therapies, Inc.

BioRestorative Therapies Announces Notice of Allowance for a New Patent Application Related to its Off-the-Shelf ThermoStem® Program

MELVILLE, N.Y., March 31, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that the...
March 22, 2021 06:00 ET | Source: BioRestorative Therapies, Inc.

BioRestorative Therapies Announces Notices of Allowance for Three Patent Applications for its Off-the-Shelf ThermoStem® Program

MELVILLE, N.Y., March 22, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that the...
March 18, 2021 16:01 ET | Source: BioRestorative Therapies, Inc.

BioRestorative Therapies Announces Filing of 2019 Annual Report on Form 10-K

MELVILLE, N.Y., March 18, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative” or the “Company”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies,...
January 05, 2021 08:00 ET | Source: BioRestorative Therapies, Inc.

BioRestorative Therapies Provides End of Year Shareholder Letter

MELVILLE, N.Y., Jan. 05, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative” or the “Company”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today...
November 20, 2020 07:00 ET | Source: BioRestorative Therapies, Inc.

BioRestorative Therapies Emerges from Chapter 11 Reorganization

MELVILLE, N.Y., Nov. 20, 2020 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative” or the “Company”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies,...
December 16, 2019 08:00 ET | Source: BioRestorative Therapies, Inc.

BioRestorative Therapies Featured in IEEE Pulse Magazine’s Cover Story About Stem Cell Therapies for Low Back Pain

MELVILLE, N.Y., Dec. 16, 2019 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative” or the “Company”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies,...
December 12, 2019 09:45 ET | Source: BioRestorative Therapies, Inc.

BioRestorative Therapies Receives Patent in Israel For Its Metabolic Program

MELVILLE, N.Y., Dec. 12, 2019 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative” or the “Company”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today...

Next Page keyboard_arrow_right